Main symposia
| S1 Diabetes in Asia I The burden of diabetes & diabetes care in Asia |
15:30~17:30 / Thursday 10 October Convention hall A Chairman:Nam Han Cho, Nader Lessan |
Overview |
|---|---|---|
Organizers: Hye Jin Lee, Tae Seo Sohn This session titled, The burden of diabetes & diabetes care in Asia, is a clinical session that is designed to provide an opportunity for clinicians to understand epidemiology of diabetes in Asia. Asian countries contribute to more than 60% of the world's diabetic population as the prevalence of diabetes is increasing in these countries. In this session, the rising trend in prevalence of diabetes, diabetes care, and socio-economic burden in each Asian country will be presented and discussed. This session will be the first step toward a better understanding epidemiology of diabetes in Asia. |
||
|
1-1The burden of diabetes and diabetes care in India | |
|
1-2The burden of diabetes and diabetes care in Thailand
 |
|
|
1-3The burden of diabetes and diabetes care in Malaysia | |
|
1-4The burden of diabetes and diabetes care in Korea | |
| S6 DKD Novel therapeutic targets in diabetic kidney disease |
09:00~10:40 / Friday 11 October Diamond hall Chairman:Hyun Shik Son, Nigel A. Calcutt |
|
|---|---|---|
Organizer: Nan Hee Kim Despite recent advances in renoprotective therapies, the reduction in ESRD rates in diabetes has been limited. Therefore, in the present session, we will present the novel potential pathways to impede the development and progression of diabetic kidney disease (DKD). 1) Adiponectin receptor agonist attenuates lipotoxicity and oxidative stress, 2) Recombinant Klotho treatment alleviates glomerular hypertrophy, 3) HIF activators are reno-protective by inducing adaptive responses against chronic hypoxia, and 4) Adenosine receptor modulators have some roles in the treatment of DKD. |
||
|
6-1Adiponectin receptor agonist in DKD | |
|
6-2Klotho plays a protective role against glomerular hypertrophy in a cell cycle-dependent manner in diabetic nephropathy | |
|
6-3Treatment of diabetic kidney disease: current and future
|
|
|
6-4Adenosine receptors as new therapeutic targets for diabetic kidney disease
|
|
| S10 Dementia Cognitive dysfunction in diabetes |
13:20~15:20 / Friday 11 October Diamond hall Chairman:Sang Ah Chang, Heiko Bugger |
Overview |
|---|---|---|
Organizers: Hyun Jin Kim This session titled, Cognitive dysfunction in diabetes is a translational session that is designed to provide an opportunity for clinicians and basic researchers to understand potential pathophysiology and clinical implications of cognitive dysfunction in patients with diabetes. The speakers will give lectures and discuss the mechanisms linked with metabolic dysfunction, and characteristics of Korean patients about cognitive impairment in diabetes. This session will be a meaningful step to find the preventive strategies and therapeutic targets. |
||
|
10-1Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications
|
|
|
10-2Metabolic dysregulation results in cognitive dysfunction
|
|
|
10-3Metabolic syndrome and brain aging | |
|
10-4Characteristics of cognitive dysfunctions in Korean diabetes patients based on the Korea National Diabetes Program Cohort | |
| S11 Diabetes in Asia 2 A shared vision to overcome diabetes in Asia |
16:20~18:00 / Friday 11 October Convention hall A Chairman:Seihyun Baik, Shashank Joshi |
Overview |
|---|---|---|
Organizers: Committee of international liaison This session titled, 'A shared vision to overcome diabetes in Asia' is a clinical session and designed to make an international occasion for gathering of Asian experts (clinicians and epidemiologic researchers) in diabetes care. The representatives from more than 6 countries from all over the Asia will present and discuss their experience in diabetes prevention, epidemiology and their healthcare system. The ultimate goal of this session resides in continuous collaboration and friendship among the Asian countries and diabetes societies in the prevention and management of diabetes in Asia in the future. |
||
|
S11-1Experience of research based on Taiwan's National Health Insurance database: taking recent analyses on insulin sensitizers and risk of dementia as examples
|
|
|
S11-2Epidemiology of diabetes and obesity in Japanese Americans and native Japanese | |
|
S11-3From starvation to obesity: what are the lessons? | |
|
Elizabeth Paz Pacheco (Philippine General Hospital, Philippines) Gangaamaa Davaanyam (Mongolian Diabetes Association, Mongolia) Renming Hu (Fudan University, China) Yong Ho Lee (Yonsei University, Korea) |
||
| S16 Cardiovascular remodeling What is the attractive target for the prevention of diabetic cardiovascular disease?: kinase, phosphatase, mitochondria, or cell |
16:20~18:00 / Friday 11 October Diamond hall Chairman:In Joo Kim , Iichiro Shimomura |
Overview |
|---|---|---|
Organizers: Jaetaek Kim This session titled, What is the attractive target for the prevention of diabetic cardiovascular disease?: kinase, phosphatase, mitochondria, or cell is a translational session that is designed to provide an opportunity for clinicians and basic researchers to understand pathophysiology of diabetic cardiovascular complications. Diabetic patients exhibit accelerated macrovascular disease, an effect that significantly contributes to increased cardiovascular events. As such, there has been a strong interest in understanding, at a molecular level, the mechanisms that increase the vulnerability of the heart and vasculature to injury in the context of diabetes. The invited speakers will present their recent works which will offer new targets for an early detection and a therapeutic intervention for cardiovascular complications of diabetes. |
||
|
16-1A novel CaM kinase activator, tetrahydrobiopterin, enhanced cardiac functions in type 2 diabetic animal model | |
|
16-2Novel endothelial protein tyrosine phosphatase in vascular wall | |
|
16-3Mitochondrial mechanisms in diabetic cardiomyopathy | |
|
16-4Adult stem cells in diabetes: beyond a regenerative tool | |
| S21 Diabetes, cardiovascular, complications Metabolic inflammation and vessel health |
09:00~11:00 / Saturday 12 October Diamond hall Chairman:Sung Rae Kim, Sabyasachi Sen |
Overview |
|---|---|---|
As an essential component of life, the inflammatory process would be everywhere all over the human body. This session was designed to glance some interesting viewpoints surrounding inflammation. Physical stress and exosomal signal might regulate inflammation. Non-regenerative neurons could be old and broken due on tiny little inflammation just for the living. The more we look around, the clearer it is: we need to control carefully with sufficient contrast, rather than simply suppressing. |
||
|
21-1Physical stress and adipose tissue response
|
|
|
21-2Adiponectin/T-cadherin system and cardiovascular protection through exosome biogenesis and mesenchymal stem cells | |
|
21-3A new approach to identifying mechanisms of neuropathic pain in patients with type 1 and type 2 diabetes
|
|
|
21-4Inflammasome-dependent metabolic inflammation in type 2diabetes | |
-
Korean Diabetes Association
101-2104, Lotte Castle President, 109
Mapo-gu, Seoul, 04146, KoreaE-mail : icdm@diabetes.or.kr
-
Congress Secretariat (The Within)
5F, Samgyeong Bldg., #100-20, Yanghwa-ro, Mapo-gu, Seoul, Korea
TEL : 82-2-6959-5333 FAX : . 82-70-8677-6333 E-mail : icdm@diabetes.or.kr
